Literature DB >> 2324147

Treatment of slipped capital femoral epiphysis. Spica-cast immobilization.

R R Betz1, H H Steel, W D Emper, G K Huss, M Clancy.   

Abstract

Thirty-two patients (thirty-seven hips) who had a so-called acute-on-chronic or chronic slipped capital femoral epiphysis were treated with traction for relief of symptoms and then with immobilization in a spica cast for eight to sixteen weeks. The disappearance on radiographs of a metaphyseal juxtaphyseal radiolucency, rather than closure of the physis, was used as the criterion for removing the cast. In one (3 per cent) of the thirty-seven hips, the slip progressed; possibly this could have been prevented by keeping the cast on for a longer period of time. Narrowing of the cartilage space was seen after treatment in a cast in seven (19 per cent) of the thirty-seven hips. In five of these seven hips, this was true chondrolysis; in one, the diagnosis of chondrolysis had been apparent before treatment. Avascular necrosis did not develop as a result of treatment in any patient. Treatment in a spica cast should be considered as an alternative for patients who have an acute-on-chronic or chronic slipped capital femoral epiphysis.

Entities:  

Mesh:

Year:  1990        PMID: 2324147

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  3 in total

1.  Nonoperative treatment of slipped capital femoral epiphysis: a scientific study.

Authors:  Pedro Carlos M S Pinheiro
Journal:  J Orthop Surg Res       Date:  2011-02-19       Impact factor: 2.359

Review 2.  Treatment of stable slipped capital femoral epiphysis: systematic review and exploratory patient level analysis.

Authors:  H Naseem; S Chatterji; K Tsang; M Hakimi; A Chytas; S Alshryda
Journal:  J Orthop Traumatol       Date:  2017-08-22

3.  EVOLUTION OF SLIPPED CAPITAL FEMORAL EPIPHYSIS AFTER NONSURGICAL TREATMENT.

Authors:  Cláudio Santili; Miguel Akkari; Gilberto Waisberg; Susana Reis Braga; Akemi Kasahara; Mauro Coura Perez
Journal:  Rev Bras Ortop       Date:  2015-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.